ANI Pharmaceuticals ANIP Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $29.49M+88.1% | $27.49M+368% | $26.62M+210% | $8.55M+474% | $15.68M-13.9% | ||
| $20.92M-8.6% | $22.61M+0.1% | $22.63M+43.7% | $23.28M+58.4% | $22.89M+55.9% | ||
| $10.19M+14.9% | $9.77M+38.3% | $9.69M+29.5% | $9.6M+22.1% | $8.87M+27.9% | ||
| $58.38M+66.8% | $30.37M+91.5% | $44.06M+253% | $75.81M+335% | $34.99M+91.5% | ||
| $6.07M+146% | $1.24M-48.0% | $6.1M+26.8% | $4.01M-9.8% | $2.47M-46.0% | ||
| -$11.32M+42.9% | -$1.4M+86.9% | -$6.16M+98.5% | -$6.91M-55.3% | -$19.85M-322% | ||
| $0-100% | $0-100% | $344K-15.3% | $407K0.0% | $406K0.0% | ||
| $19.76M+97.5% | $611K+92.1% | $1.04M+53.5% | $551K-57.6% | $10M+15.5% | ||
| $4.06M+100% | -$6.09M-102% | $2.03M— | $2.03M+171% | $2.03M+171% | ||
| -$21.62M-118% | -$4.64M— | —— | -$1.75M-20.3% | -$9.91M+49.8% | ||
| $25.59M+418% | $22.98M+18,779% | $44.81M+147% | $68M+491% | $4.94M-33.9% | ||
| $52.3M+60.8% | $29.12M+116% | $37.95M+395% | $71.8M+454% | $32.52M+138% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ANI Pharmaceuticals generate?
- ANI Pharmaceuticals (ANIP) generated $208.6M in operating cash flow over the trailing twelve months.
- What is ANI Pharmaceuticals's free cash flow?
- After $17.4M of capital expenditures, ANI Pharmaceuticals's free cash flow was $191.2M over the trailing twelve months, up 187.0% year over year.
- Where does ANI Pharmaceuticals's cash flow data come from?
- Every line is extracted from ANI Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
